Search for: "ANDRX Pharmaceuticals, L.L.C."
Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
12 Feb, 2007 9:37 pm by Aaron Barkoff
... suit was filed in the Southern District of Florida in December 2005 by Andrx Pharmaceuticals, which was acquired by Watson last year. Andrx asserted that Glaxo's formulation for Wellbutrin XL ... No. 6,905,708, entitled "Controlled Release Oral Dosage Form." Andrx is seeking to market a generic version of Wellbutrin XL and has filed an ANDA ... may have sought to gain the upper hand in Biovail's case against Andrx in New York, perhaps hoping to settle the case on terms that it would allow it to sell ...
Orange Book Blog - http://www.orangebookblog.com/
16 Oct, 2006 7:58 pm by Aaron Barkoff
... the new lawsuits. New lawsuits filed: Biovail Laboratories filed a new lawsuit against Andrx Pharmaceuticals over Andrx's attempt to market generic Cardizem. Novartis sued Par Pharmaceuticals, the third and most recent company to file an ANDA for generic Lotrel. Schering-Plough sued over a dozen ... Disorder (ADD), had sales of $846 million last year. Alza had also sued Andrx over its own ANDA, but the Stipulated Order dismissing the suit did not mention the case ...
Orange Book Blog - http://www.orangebookblog.com/
2 Sep 11:22 pm by Beck/Herrmann
... other hand, there's Lake-Allen v. Johnson & Johnson, L.P., 2009 WL 2252198, at *3-4 (D. Utah July 27, ... Pacesetter, Inc., 259 F. Supp.2d 27, 36 (D.D.C. 2003) (fraud on the FDA allegations embedded in warning claim preempted; "plaintiffs cannot ... defendant's alleged failure to report and to investigate adverse incidents to the FDA"); Andrx Pharmaceuticals v. Biovail Corp., 175 F. Supp.2d 1362, 1369 ... Supp.2d ___, 2009 WL 2424559, at *11 (M.D.N.C. Aug. 5, 2009); Link v. Zimmer Holdings, Inc., 604 F ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
2 Aug, 2008 12:54 am
... - US: Celgene wins bid to have Buchanan Ingersoll disqualified from representing KV Pharmaceutical in longstanding patent dispute over Ritalin: (Law360), Sensipar (Cincalcet hydrochloride) - US: ... class actions claiming Biovail violated antitrust law by using patent litigation to keep Andrx from making generic Tiazac: (Law360), Viread (Tenofovir) - UK: British court allows ... R Bard - Court validates C R Bard's prosthetic blood vessel graft in case against W L Gore & Associates: (Law360), Canon ...
IP Thinktank - http://duncanbucknell.com/blog
25 Jul, 2007 3:15 pm by Stephen Albainy-Jenei
... Court of Appeals for the Federal Circuit, No. 06-1254. AstraZeneca sued after Andrx filed an Abbreviated New Drug Applications (ANDA) seeking FDA approval to market ... (A1, A2, A3, etc.), an inner layer (B), and an outer layer (C). Specifically, it would have been an obvious variation of Claim 8 of the '318 Patent to ... claiming pharmaceutical composition with "enhanced storage stability, the closed container, [and] the packaged unit-dosages"). The court noted that In re Schneller, 397 F.2d 350 (C.C ...
Tags: Current, Affairs
Patent Baristas - http://www.patentbaristas.com/
25 Jul, 2007 8:10 pm by Aaron Barkoff
... , the active ingredient in Astra's blockbuster cardiovascular drug Toprol-XL. KV Pharmaceutical, Andrx, and Eon Labs have all filed ANDAs for generic Toprol-XL ... . Patent No. 4,780,318. The '318 patent expired in 2005 and claims pharmaceutical compositions containing one of a number of active ingredients (including metoprolol succinate), while the ... (A1, A2, A3, etc.), an inner layer (B), and an outer layer (C). Specifically, it would have been an obvious variation of Claim 8 of the '318 Patent to ...
Orange Book Blog - http://www.orangebookblog.com/
         
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck